World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 29 June 2015
Main ID:  NCT02476461
Date of registration: 05/06/2015
Prospective Registration: No
Primary sponsor: Oslo University Hospital
Public title: Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture PNFvsxiapex
Scientific title: Prospektiv Randomisert Sammenlikning Mellom Percutan nålefasciotomi og Xiapex for Dupuytrens Kontraktur
Date of first enrolment: April 2015
Target sample size: 50
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02476461
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Norway
Contacts
Name:     hallgeir bratberg, MD
Address: 
Telephone: +4790578848
Email: hbratber@ous-hf.no
Affiliation: 
Name:     hallgeir bratberg, MD
Address: 
Telephone:
Email:
Affiliation:  Oslo University Hospital
Name:     hallgeir bratberg, MD
Address: 
Telephone: +4790578848
Email: hbratbe@ous-hf.no
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- symptomatic Dupuytrens contracture with palpable cord, involving MCP, total
contracture size over 30 degrees

Exclusion Criteria:

- previous treated dupuytrens contracture same hand

- more than tree fingers involvement

- we will not include thumbs

- other things affecting hand function

- ASA>3

- expected to live under five years

- Tetracycline treatment within two weeks

- pregnancy

- nursing

- allergy to clostridium histolyticum

- participant in other trial



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Dupuytrens Contracture
Intervention(s)
Drug: xiapex
Procedure: percutaneous needle fasciotomy
Primary Outcome(s)
contracture size (degrees) [Time Frame: five years]
Secondary Outcome(s)
contracture size [Time Frame: post treatment]
Secondary ID(s)
1234
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history